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he field of health law offers a
multitude of issues for thoughtprovoking scholarship ranging
from whether or not to allow human
cloning or whether to regulate IVF and
genetic testing, to issues of financing.
the regulation of managed care, health
insurance and fraud and abuse. Faculty
at the University of Maryland School of
Law have written on many of these
issues and continue to pursue research
and scholarship on new and emerging
issues in health care, public health and
bioethics. In some cases. the issues
arise from their clinical practice, in
others it may come out of a project in
which they participated as a task force
member or consultant, and for some it
may be a direct result of their teaching
experience. While much of the scholarship is based on traditional analysis of
legal reasoning and policy, a good

T

amount of faculty scholarship is based
on empirical research and draws from
other disciplines including economics,
philosophy and sociology. The vast
array of health law and policy issues on
which University of Maryland faculty
arc working, how they became interested in a particular topic, and some of
the issues they are planning to pursue
in the coming year are the focus of this
feature article.

Research Spotlight:
Professor Irving Breitowitz
While he is primarily known at the
Law School for his teaching in the area
of commercial law. Professor Irving
Breitowitz's scholarship has focused
extensively on issues of medical ethics.
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T enriched by the wide ranging areas of research pursued by our faculty. Not
only are faculty working on issues in bioethics and genetics, Medicare and
fraud and abuse, but they are also exploring issues in public health, international health, and intersections between health law and family law. In addition
to our feature article, we share news of several interdisciplinary courses and
upcoming events, spotlight one of our most popular adjuncts, and let you know
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what our Student Health Law Organization is up to. We hope you find the issue
informative.
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tradition, reproductive cloning may
have positive benefits.

Professor Breitowitz. who is also a rabbi
at the Woodside Synagogue in Silver
Spring, Maryland, has recently published articles about the ways that Jewish Law can guide difficult decisions
presented by newly developed reproductive technologies. Although Jewish
law is not a legally enforceable system
anywhere in the
world, it is a
system of law
and ethics that
thousands of
people worldwide consider
binding.
In his article,
"Halakhic Alternatives in IVFPregnancies: A
Survey," which appeared in The Jewish
Law Annual,' Breitowitz discusses the
ethical dilemmas that have been created
by proliferated use of IVF technologies. In the article, he examines how
Halakha, a religious system premised on
subservience to divine will, may provide
answers to the moral quandaries presented by disposition of fertilized ova,
implementation of some or all pre-embryos, destruction of pre-embryos and
donation of pre-embryos to other
women for surrogacy.
Professor Breitowitz has also devoted some of his recent scholarship to
the issue of human cloning. In one
article, titled "What's So Bad About
Human Cloning?" featured in the
Kennedy Institute of Ethics Journal,'
Breitowitz analyzes the religious and
ethical issues surrounding cloning for
reproduction. This article challenges
the assumption that reproductive cloning is a dangerous phenomenon that is
morally repugnant. Breitowitz argues
that from the perspective of the Jewish

Footnotes
' The Jewish Law Annual,
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Vol. XIV, p. 30
(April 2003).
' Kennedy Inst. of Ethics J. 2002 Dec; 12
(4):325-4 I.

Professor Kathleen Hoke
Dachille
Professor Dachille is the Director of
the Tobacco Control Center at the University of Maryland School of Law.
She also directs the Tobacco Control
Clinic, which
provides law
students with
hands-on experience in bill
drafting, legislative advocacy
and litigation in
the tobacco
control arena.
Professor
Dachille's academic scholarship is currently focused
on the authority of family courts to
stop parents from exposing children to
secondhand smoke. She is working to
complete an article on the family
courts' activity with respect to prohibition of parent smoking.
Her research in this area is based, in
part, on two recent family court decisions in which the judges prohibited
parents from smoking in their home or
persona] vehicle to protect a child subject to an order of custody and visitation.
The New York case, De,'Llatleo 1'.
De.Matteo, 749 N.Y.S. 2d 671 (October 9, 2002), originated when 14-yearold Nicholas filed a complaint seeking
to enjoin his mother from smoking in
his presence during court-ordered visi-

Focus on.

SCHOLARSHIP ON THE CUTTING EDGE
tation. According to Nicholas. his
mother smoked in her apartment and
car when he was present. His mother,
however, denied exposing the child to
secondhand smoke. Ms. DeMatteo
also contested the court's interim decision to take judicial notice of the fact
that secondhand smoke poses significant health risks to nonsmokers, presenting evidence in opposition to that
finding.
The court conducted its own research and review of scientific data and
analysis on secondhand smoke. Based
on the results of that research and on
the fact that the New York state legislature in 1989 passed a law recognizing
the dangers of' secondhand smoke. the
court took judicial notice of the fact
that secondhand smoke is a carcinogen
that can cause lung cancer in otherwise
healthy nonsmokers. The court also
took notice that children of smoking
parents suffer increased incidence of
respiratory infections and diminished
lung capacity.
As a result of its findings, the court
ordered that Nicholas' home with his
father be smokefree and that the boy's
mother not smoke in her apartment
when Nicholas is present or for
twenty-four hours in advance of a
scheduled visit. The order also prohibits both parents from smoking in a car
when Nicholas is present. The court
considered it to be in Nicholas' best
interest to limit the boy's exposure to
secondhand smoke.
_
An Ohio court similarly used the best
interest standard to reach a comparable
decision in In re Julie Anne, 2002 WL
20221 17 (August 27. 2002). In that
case, the Court of Common Pleas of
Ohio issued a restraining order prohibiting Julie Anne's parents from smoking,
or allowing others to smoke, in the
child's presence. In addition, the court
independently raised the issue of the
dangerous effects of childhood exposure to secondhand smoke during a
routine visitation hearing. The court

was clear in its opinion that family
courts have the unqualified duty to
consider the harm caused by secondhand smoke to children subject to a
custody or visitation order.
In reaching its decision, the court
examined numerous scientific studies
finding a causal relationship between
exposure to secondhand smoke and
health problems in children. Concluding that secondhand smoke is a human
carcinogen, responsible for more than
3.000 lung disease deaths annually in
the United States, the court looked at
the specific harm faced by children
exposed to secondhand smoke and
noted that every independent scientific
study on secondhand smoke has concluded that exposure causes and aggravates numerous diseases and illnesses
in children, including bronchitis, pneumonia, asthma, chronic respiratory
problems, and middle ear infections.
Also persuasive to the court were studies showing that children are more
likely to become smokers when exposed to their parents' smoking. Because of the egregious harm to Julie
Anne from her parents' or others' tobacco use in her presence, the court
ordered that her parents not smoke and
not allow others to smoke in the
child's presence.
The court not only determined that
such an order was appropriate in this
case but stated that, " . . . a family
court that fails to issue orders restraining persons from smoking in the presence of children within its care is failing the children whom the law has
entrusted to its care."
Just as there have been an increased
number of jurisdictions that regulate
smoking in the workplace and in public
places, it is possible that there will be
an increase in the number of family
court custody and visitation orders
protecting children from exposure to
secondhand smoke in the home. According to Professor Dachille, given
the significant number of children sub-

ject to court-ordered custody and visitation, a trend in that direction could
have a profound impact on the health
of our children and those in the generations to come.

Professor Deborah
Hellman
Professor Deborah Hellman teaches
the "Principles of Bioethics Seminar" at
the School of Law and has focused
some of her scholarship on issues at
the intersection of health law and philosophy. She recently published two
health law related articles. In one
piece, "Evidence, Belief and Action:
The Failure of Equipoise to Resolve the
Ethical Tension in the Randomized
Clinical Trial,"
published in the
Journal of Law,
Medicine &
Ethics in 2002,'
Hellman argues
that the concept
of equipoise is
unable to dissolve the ethical
tension inherent
in the randomized clinical trial [RCT]. Traditionally
the RCT is understood as involving an
ethical conflict between the interests of
the patients in the trial who seek the
best available treatment for their disease and the interests of society and
future patients in gaining reliable information reasonably quickly about what
treatments are best for the disease in
question. It is often argued that this
tension is illusory or can be alleviated in
those situations where it is not known
which treatment is best. When the
scientist conducting the trial, the physician enrolling patients in the trial and
the medical community as a whole
don't know which of the treatments
offered in an RTC really is best (equiCont. on page 4
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poise), then perhaps patient interests
are not compromised in order to produce a societal benefit as all patients
get equal care.
In the article, Hellman argues that
this standard defense of RCTs is conceptually flawed. While others have
critiqued the equipoise standard in important ways, her article offers a new
and more basic critique of the ability of
equipoise to alleviate the ethical tension
in clinical trials. Equipoise is a standard that relates to belief One is in
equipoise about which treatment is best
if one doesn't have reason to believe
that treatment A is better, all things
considered, than treatment B. But for a
sick person considering treatment, the
question is not what to believe, it is
what to do. This is important because
the criteria for answering each question
(what should I believe and what should
I do) are significantly different. For
example, for a very sick person for
whom no good treatments are available, it may well make sense to try a
therapy she doesn't have good reason
to believe will work. Conversely, for
the healthy volunteer, it makes sense to
require a very high degree of confidence that a dru g or other intervention
is safe before trying it.
In a second health-related article,
Hellman assesses the moral and policy
arguments for legislation forbidding
genetic discrimination. That article, "Is
Genetic Discrimination Exceptional?"
recently appeared in the American
Journal of Law & Medicine.' The issue is timely. Many states have passed
laws, which vary in scope and in
strength, that forbid genetic discrimination. As the academic literature has
matured, the question that has come to
dominate that literature is whether genetic discrimination is meaningfully
different from discrimination on the
basis of health status more generally.
4

Those who think that genetic discrimination is not meaningfully different
from general health status discrimination often argue that any protections
from discrimination should be "generic" rather than "genetic"-so that
no one who is sick can be denied insurance, employment or others benefits
on that basis. Others continue to
maintain that there is something meaningfully different about genetic discrimination that differentiates it from
health-based discrimination and thus
that the special protections from genetic discrimination that have been enacted are justified.
Professor Hellman's article enters the
debate at this point. It canvases the
familiar arguments that have been offered in support of the view that genetic discrimination is different and
argues that most of these are
unpersuasive. The article then goes on
to evaluate two arguments for genetic
exceptualism (as this position has been
called) that have been largely neglected.
The first asserts that genetic discrimination is different and warrants special
protection in order to safeguard the
health enhancing potential of the Human Genome Project. Perhaps
people's fears of discrimination will
keep them from participating in research involving genetic testing. If so,
research that will promote health will
be thwarted. In the article, Hellman
asserts that this is an important argument for special genetics legislation but
that its soundness depends on the answers to several empirical questions
that require further investigation. In
particular. even if people say they fear
genetic discrimination, the types of
discrimination that people actually fear
must be examined. If people fear that
they will be unable to get life insurance
or long-term care insurance, then a law
that forbids genetic discrimination in
health insurance will have little effect.
In addition, we need to know how significant a role these fears play in
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people's decisions regarding whether
to undergo testing in order to know
whether laws forbidding genetic discrimination will have the desired effect.
Second, Hellman explores the argument that genetic discrimination ought
to be forbidden because of what it expresses. Here the claim is that the social meaning of genetic discrimination
is different from health-based discrimination because of the unfortunate history of the misuse of genetics in this
country and in Europe for eugenic purposes. In her view, this argument underlies much of the commentary on
genetic discrimination but has not yet
been clearly articulated and defended.
Professor Hellman's article adds to the
debate by providing an in-depth exploration of this defense of genetic
exceptualism.
Footnotes
1

30 .!. of.. LAwa Men. & ETHICS 375 (2002).
29 .4w. J. of Law & Med. 77 (2003).

Associate Dean Diane
Hoffmann
For the last six years, Dean
Hoffmann has been a Mayday Scholar,
focusing much of her research and
scholarship on legal and policy obstacles to the adequate treatment of
pain. The Mayday Scholars Program is
funded by the Mayday Fund, which is
dedicated to alleviating the incidence,
degree and consequence of human
physical pain. In the course of that
time, she has completed articles on
insurance and managed care and how
they influence the provision of pain
treatment, gender bias in the treatment
of pain, and, most recently, on the
attitudes and practices of state medical
boards regarding how they balance the
need for adequate pain treatment with
concerns about drug diversion and
inappropriate prescribing.
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In addition, as an outgrowth of a two
year project that included several
studies regarding obstacles to pain
management in Connecticut, funded by
the Donaghuc Medical Research
Foundation, Hoffmann became interested in the use of hospice services by
long term care
facilities. It
appeared that
nursing homes,
at least in
Connecticut,
made very little
use of hospice
services for
their terminally
ill residents.
Upon subsequent research, Hoffmann found that
this was generally true across the
country, and began to consider the
possible reasons for the low utilization
rate. This led her to consider relatively
recent fraud alerts and opinions by the
OIG regarding nursing home-hospice
contractual relationships and whether
they might have had a negative impact
on the willingness of nursing homes to
contract with hospices. As a result,
Hoffmann undertook an empirical
study of nursing homes and hospices
in Maryland to determine the primary
obstacles to their contractual relationships. She recently completed the
study, which was funded by the
Borchard Foundation on Law & Aging,
and hopes to have it published in a
forthcoming issue of a health policy
and law journal.
Another area in which Dean
Hoffmann has focused some of her
scholarship is human subjects research, particularly as it deals with
incapacitated subjects. This interest
and scholarship was the result of
participation on a task force appointed
by the Maryland Attorney General to
develop guidelines and proposed
legislation for research with this
population. This interest led her, during

the past year, to coauthor an article
with her colleague. Dean Karen
Rothenberg, on research with children.
The article focused on the implications
of the Maryland Court of Appeals'
decision in the case of Grimes v.
Kennedy Krieger, for public health
research and the duty, as a legal
matter, of public health researchers. In
the article, Hoffmann and Rothenberg
assert that the opinion of the Court of
Appeals seems to confuse the research
intervention with the living/housing
conditions of the plaintiffs, resulting in
a duty to disclose risks related to lead
based paint which were arguably not a
result of the research intervention but
of which the researchers were aware.
They argue that this broad based duty
may have negative repercussions for
public health research and for society
at large, which benefits from such
research findings.
Hoffmann is now on sabbatical, and
her sabbatical project is leading her into
a somewhat new area of research. She
will be looking at how courts are using
genetic test results for purposes of
determining the health status of one of
the parties. While the use of genetic
tests by courts has been well established in criminal and paternity cases as
a way to determine "identity," there are
a handful of cases reported in the
literature where courts have compelled
genetic tests or admitted them into
evidence for the purpose of determining someone's current or future health
status. Most of these cases have been
in the torts area, a few have been in
family law. Hoffmann became interested in the issue after having been
asked to speak at conferences sponsored by the Alpha-1 Foundation and
the University of Rochester Medical
Center on non-therapeutic uses of
genetic information and, in particular,
how genetic information is being used
by the courts. Whether or not courts
admit or compel such information is
largely determined in the context of

unreported evidentiary motion decisions. As a result, part of the study will
include interviews with trial court
judges about whether they have been
asked by one or more parties to admit
into evidence, or compel, genetic tests
for the purpose of determining health
status. The study is part of a larger
research question that has interested
Hoffmann, that is, how courts deal
with new medical technologies and
when they consider them relevant as a
matter of evidence. For example, do
they consider the specificity or sensitivity of the test results? Do they
consider the invasiveness of the test
and the privacy concerns of individuals
in having the test performed or admitted? Hoffmann believes that the issue
has broad ramifications for the use of
certain diagnostic tests. As regards
genetics, how courts decide the issues
may significantly affect the privacy,
not only of parties, but also of their
family members, and may affect the
number of individuals who seek genetic
tests for therapeutic purposes.

Professor David Hyman
Professor David Hyman teaches
Health Care Regulation at the School of
Law and is currently serving as Special
Counsel at the Federal Trade Commission (FTC). Over the last several years,
Professor Hyman's scholarship has
focused on the regulation and financing
of the health care industry. His work
at the FTC has given him the opportunity to coordinate a wide-ranging set of
hearings on competition law and
policy in the health care marketplace.
The hearings have been jointly
sponsored by the FTC and the
Department of Justice. In June,
Professor Hyman made a presentation
at these hearings entitled "Mandated
Benefits: A Behavioral Economics/
Comparative Institutional Perspective."

Cont. on page 6
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While his work at the FTC has taken
up most of his lime during the past year,
and will continue to do so in the coming
year, Hyman has kept up his scholarship
in a number of areas. In February, he
participated in a symposium on Law and
Human Dignity at Notre Dame Law
School and spoke as part of a panel that
addressed issues related to "Technology, Ethics & Human Dignity." The
panel members discussed the challenges
that political communities face when
attempting to craft legal responses to
advances in technology and how
society's increased reliance upon
technology shapes our views of human
dignity. The article that Professor
Hyman presented at this symposium,
entitled "Does Technology Spell Trouble
With a Capital T?: Human Dignity and
The Relief of Man's Estate,"' will be
published in a forthcoming issue of the
Harvard Journal of Law & Public
Policy.
In March,
Professor Hyman
participated in a
symposium on
the "Future of
Medicare" at
Washington &
Lee University
School of Law.
His remarks
explored the
political and policy dynamics of
reforming the Medicare program. The
article that Professor Hyman presented
at this symposium, "Medicare: Did the
Devil Make Us Do It?," will be published in a forthcoming issue of the
Washington & Lee Law Review.
Professor Hyman is currently
working on several projects, including
articles on medical malpractice, the
complexities of translating economic
analysis into competition policy, and an
empirical study of the no-duty-torescue doctrine.

ProfessorThonlas Perez
Professor Perez leads the "Access to
Health Care for Vulnerable Populations"
Clinic at the School of Law. Before
coming to the law school in 2001, Perez
served as Director of the Office of Civil
Rights at the
United States
Department of
Health and Human
Services. This
work led him to
focus his research and
scholarly activities at the law
school on issues
at the intersection
of health care and civil rights, in particular, efforts to eliminate racial and ethnic
disparities in health status. Professor
Perez' article, "The Civil Rights Dimension of Racial and Ethnic Disparities in
Health Status," appeared in the seminal
Report issued by the Institute of Medicine in 2002: Unequal Treatment:
Confronting Racial and Ethnic Disparities in Health Care. Earlier this year, he
authored a paper for the American
Institutes of Research (AIR) on the
"Legal and Regulatory Landscape
Surrounding the Obligation of Health
Care Providers To Ensure Meaningful
Access To Health Care For People with
Limited English Proficiency." This
paper was prepared in connection with a
grant that AIR received from the Office
of Minority Health of the United States
Department of Health and Human
Services to address cultural competency
in health care delivery.
Along with his research and scholarship on reducing disparities in health
care, Professor Perez has been very
active in efforts to increase racial and
ethnic diversity in the health professions. He views this work as a critical
strategy for addressing the disparities
challenge. In this effort, he collaborated
with the Association of American
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Medical Colleges (AAMC) on their
initiative to revamp the definition of
"Underrepresented Minority. " This
definition is used by medical schools
across the country in their efforts to
enhance diversity. The AAMC recently
approved the revised definition following
a multi-year process. In addition to his
work with AAMC, Perez was recently
appointed to the Sullivan Commission on
Diversifying the United States
Healthcare Workforce. The Commission
was established by the Kellogg Foundation to develop a blueprint for increasing
racial and ethnic diversity in the health
professions. The Commission is
conducting field hearings across the
United States and will issue a report in
the spring of 2004.
Perez is also currently a finalist for a
Robert Wood Johnson Investigator Award
in Health Policy Research. His research
proposal focuses on developing new
strategies for increasing diversity in the
health professions in light of the recent
Supreme Court decisions upholding the
constitutionality of race-conscious
admissions policies in higher education.

Dean Karen Rothenberg
Karen H. Rothenberg is the Dean of
the law school and the founding Director of its Law & Health Care Program.
During the last decade, Rothenberg has
focused her research and scholarship on
the integration of her two primary
interests: women's health and genetics.
In 1995, while on sabbatical from
teaching at the School of Law, she
served as the Special Assistant to the
Director of the Office of Research on
Women's Health at the National Institutes of Health (NIH). Though
Rothenberg has written extensively
about a variety of health law topics,
such as AIDS, the right to forego
treatment and emergency care, her
experience at NIH fueled her interest
with respect to the possibility of dis-
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crimination against specific racial or
ethnic groups based on the results of
genetic testing.
Research breakthroughs that occurred
in the 1980s and 1990s permitted
scientists to identify genes that were
believed to cause inherited diseases.
Rothenberg recognized that, along with
their great potential for treatment and
cure of diseases, the results of genetic
testing, especially if focused on a
particular racial or ethnic group, could
lead to the stigmatization of members of
these groups.
By the midnineties, researchers had
demonstrated that
a genetic mutation linked to
breast and
ovarian cancers
(BRCAI and
BRCA2)may
occur with
greater frequency
among Ashkenazi
Jews. As a result of this finding, many
Jewish women volunteered to participate in research related to the BRCAI
and BRCA 2 gene. With the findings of
these two genes Rothenberg identified a
need to re-focus attention on the risks
and benefits of genetic research performed on specific ethnic or racial
groups. She realized that if identifiable
ethnic groups are predisposed to
develop a disease, it is likely that
members of these groups could be
stigmatized or discriminated against in
the workplace or with respect to
insurance.
Rothenberg's research in this area
raises complex issues regarding the
benefits of targeted genetic research.
Although scientists will be better able to
research diseases that disproportionately
impact certain ethnic groups,
Rothenberg argues that we must
consider the countervailing concern that
the participant ethnic group members
will experience stigmatization and

discrimination.
Over the last five years, Rothenberg
has published a number of articles in
this area, including the findings oilier
empirical study on attitudes about
genetic research in the Jewish population. The study found that most
research subjects would be willing to
provide consent for future testing on
their tissue if the research was related to
curing preventable diseases, such as
heart disease, but less willing to consent
to research on behavioral traits.
Rothenberg's current research traces
the historical evolution of the use of
genetic information and the Jewish
community from the eugenics movement at the turn of the century, to the
discovery and expansion of Tay-Sachs
testing, to the current marketing of
genetic testing for the predisposition to
disease. Rothenberg will present this
research at the American Society for
Bioethics and HumanitieslCanadian
Bioethics Society joint conference in
Montreal in October 2003. She hopes to
further stimulate bioethicists and health
law attorneys to work together with the
research community on considering new
approaches to the evaluation of the risks
and benefits of genetics research on
racial and ethnic groups.

Professor Allyn Taylor
Professor Taylor is an adjunct professor in residence at the School of Law
and a member of the adjunct faculty at
the Johns Hopkins Bloomberg School of
Hygiene and Public Health. For the past
nine years she has also served as a
Health Policy Adviser to the World
Health Organization. She teaches a
seminar on "International Public Health
Law" at the School of Law. This past
summer, Professor Taylor was involved
in a variety of scholarly projects that
revolve around her interest in the impact
that international law and institutions
have with respect to the advancement of
global public health.

One of her projects is the development of "case studies" that demonstrate
the application of international health law
in various contexts as well as projects
that consider overarching issues in global health governance. For example,
Professor Taylor recently completed a
chapter on the proposed UN convention
on reproductive cloning for a forthcoming book, Biotechnologv, Intellectual
Praperti.' and Ethics: An Interdisciplinary Reader, edited by Jensine
Andreson, to be published by Cambridge
University Press. The chapter examines
the strengths and limitations of international law and the international legal process in promoting a global ban on human reproductive cloning. Taylor attended the cloning negotiations as the
legal adviser for the World Health Organization (WHO) and was asked to contribute the chapter following her participation in a conference at Boston University on biotechnology and intellectual
property last year that was organized by
Professor Andreson.
Taylor is also working on a short
piece about the origins of the WHO
Framework Convention on Tobacco
Control (FCTC) that was adopted by the
World Health Assembly in May. She
developed the idea of a framework convention approach to tobacco control as
part of her doctoral dissertation almost
ten years ago and was the senior WHO
legal advisor for the negotiation process.
This piece, written with Professor Ruth
Roemer, adjunct professor emeritus at
the UCLA School of Public Health, and
Jean LaRiviere, the Canadian delegate to
the World Health Organization, provides
an historical account of the origins of the
FCTC and examines the way in which
the idea gained momentum globally.
In addition to examining specific
treaty processes, Professor Taylor has
become increasingly interested in the
role of international law and institutions
in contemporary global health governance. One of the most interesting
Cont. on page 8
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SCHOLARSHIP ON THE CUTTING EDGE
Focus on .. .
Cont. from page 7
projects in which she is currently involved is the World Bank/NM/WHO
Disease Control Priorities Project. The
articles produced as a result of this extraordinary project, which involves 80
teams of authors, will be published by
Oxford University Press. As part of this
effort, Taylor is co-authoring a chapter
on priorities for future international
health lawmaking. She is excited to
have the opportunity to work with an
interdisciplinary team of economists and
epidemiologists on this project which
has the potential to impact future global
public health policy.
Taylor also recently completed an
article entitled, "Governing the Globalization of Public Health," for the American Journal of Law, Medicine & Ethics.
This article was a solicited piece for a
special theme issue on emerging issues
in health law. The article examines how
globalization is a driving force behind
the burgeoning field of international
health law. It also considers how the
contemporary international organizational framework poses a severe challenge to the rational development of an
effective international health law regime.
Finally, during the past summer, Professor Taylor and Professor Roberto
Andorno, a leading bioethicist and the
Argentinean delegate to the UNESCO
Bioethics Commission, prepared a proposal for a book, International Biomedical Law: Theory and Practice that has
recently been accepted for publication
by Transnational Publishers. Taylor's
contribution to this book will bridge her
interests in specific treaty processes and
in the management of international
health law generally. She will examine
the role that UNESCO, WHO and the
UN take with respect to the advancement of international cooperation in various realms of biotechnology.

8

Professor EllenWeber
Professor Weber leads the Drug
Policy and Public Health Strategies clinic
at the School of Law. Her current
scholarship builds on her work of
promoting policies that address alcoholism
and drug dependence as a health, rather
than criminal justice, issue and expand
access to community-based
treatment services.
Professor Weber
is completing an
article that
examines the
challenges of
establishing
community-based
treatment services and the
various legal,
educational and advocacy strategies that
can he used to overcome community
opposition to siting programs. The
article asserts that the siting dilemma
grows out of a number of factors
including the lack of integration of
alcohol and drug treatment services into
the primary health care delivery system,
the limited education among health care
providers about these diseases, the lack
of public understanding about the
origins, progression and treatment of
these medical conditions, and the
emphasis in national and local policymaking on punitive rather than public
health solutions to alcoholism and drug
dependence. Weber contends that lack
of public awareness at the community
level compounds the stigma associated
with alcoholism and drug dependence
and thus opposition to treatment services persists, regardless of the location
that is selected for a program, the
treatment modality or the credentials of
the provider.
Professor Weber's research and
hands-on work to address discriminatory zoning practices suggest that
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multiple short and long-term strategies
are needed to overcome opposition to
treatment programs. She believes that
better education about these medical
conditions and their treatment, stricter
enforcement of civil rights laws that
prohibit discrimination against persons
with disabilities, increased collaboration
between service providers and communities to address local needs, and better
integration of treatment services within
the primary care system will decrease
opposition to treatment programs.
Over the past year, Weber has
become increasingly interested in the
integration of treatment services into the
primary health care system as a result of
her participation on an Institute of
Medicine/National Academy of Sciences
committee that studied immunotherapies
for drugs of addiction. lmmunotherapies are now being developed that could
enable persons with drug dependence to
receive medication-based therapy in a
primary care setting with linkages to
other counseling and supportive services. The use of these medications,
while holding great promise, raises a
host of ethical and legal dilemmas,
particularly when considered for use
among vulnerable populations, such as
pregnant and parenting women and
adolescents. Protocols for the appropriate use of immunotherapies among such
populations will need to be developed to
protect against inappropriate or coercive
use. Weber hopes to conduct future
research in the area of immunotherapy
use, specifically focusing on the chief
concerns about the use of these drugs
by pregnant and parenting women.

Focus on.

SCHOLARSHIP ON THE CUTTIN G EDGE
Professor Deborah Weimer
Professor Weimer leads the School of
Law's HIV clinic. Her clinical work
with HIV+ pediatric and adolescent patients and their
families has
guided her academic research
priorities which
are focused on
medication adherence and alleged
medical neglect.
Through her
practice, Weimer
found that physicians and social
workers with whom the clinic students
worked would. on occasion. file reports
with protective services alleging parental
neglect in hopes that system support
and assistance would help at-risk patients and their families adhere to difficult medication re gimens used to treat
HIV illness. Based on the insights that
she and her students gained while representing parents in these cases, Professor
Weimer recently published an article entitled "Medical Treatment of Children
with HIV Illness and the Need for Supportive Intervention: the Challenges for

Medical Providers, Families and the
State."' The article argued that an alternative system would be better able to address the needs of these families. Her
thesis is that there is a need for a system that focuses on preventing harm to
children, rather than making a legal determination of whether neglect is "indicated." Because of this focus on
whether neglect had occurred, the
Maryland Department of Social Services would often not intervene until
the harm to the child had already happened, e.g., resistance to a whole class
of medications had developed.
Professor Weimer is currently in the
process of researching the degree to
which the quality of the physician/patient
relationship is a determinant in medication
compliance. She is developing an interdisciplinary project to meet the needs of
children and families at risk. As part of
this project, she plans to establish a research arm which will look at the role
that racial, cultural and class differences
between the physician and the family play
in a family's willingness to adhere to the
prescribed regimen.
During the previous academic year,
Professor Weimer and her clinical students were involved in a collaborative
project with the Schools of Social Work

and Nursing to provide services to families consisting of grandparents with
grandchildren who are HIV positive. A
small grant supported this work. Professor Weimer and the clinic students submitted a grant proposal to continue the
interdisciplinary project. The proposal
included a research piece that would examine the role that access to legal services plays in stabilizing these families.
In the proposed project, families would
be randomly assigned to different levels
of service, and a variety of criteria would
be used to assess impact.
Finally, Professor Weimer is working
on questions of consent to enrollment in
clinical trials for HIV+ adolescents,
many of whom do not have a parent or
guardian available to consent on their
behalf. Issues she will be addressing
include the factors that should be considered in determining what is an appropriate alternative mechanism to protect
the interests of these adolescents. She
had been working with a medical clinic
that serves HIV+ adolescents that is a
site for a clinical trial. The goal of the
medical clinic is to improve medication
adherence among HIV+ adolescents.
Footnotes
Juvenile and Family Court Journal, Vol. 54
ill (Winter 2003).

Robin F. Wilson Joins Faculty
as Visiting Professor
he L&HCP welcomes Professor
Robin F. Wilson, who is visiting
at the law school this semester.
Professor Wilson comes to Maryland
from the University of South Carolina
School of Law, where she has been a
member of the faculty since 1998. This
fall she is teaching one of the core
health care law courses, "The PatientProvider Relationship," along with a
course on insurance law.
Professor Wilson received her BA
and JD from the University of Virginia
and upon graduation from the School
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of Law, clerked for the United States
Court of Appeals for the Fifth Circuit.
After clerking, Wilson worked in the
Houston law offices of Fulbright &
Jaworski and Mayor, Day, Caldwell
and Keeton. While in private practice,
she worked in the field of health care
law.
At the University of South Carolina,
Wilson has served as the faculty
advisor to the Health Law Society.
She also directs the "Students Assisting
Seniors" project, an interdisciplinary
endeavor that involves students from

the Schools of Law, Medicine, Nursing,
Social Work and Public Health. Students involved with the "Students
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Cont. on page 10
Law & Health Care Newsletter 9

Associate Dean Hoffmann Takes Hollywood
n August 20, 2003, Associate
Dean Diane Hoffmann
participated in a Hollywood
writer's roundtable on pain management at Universal City, California. The
roundtable was sponsored by Progress
on Pain, an educational activity of the
Mayday Fund, a foundation dedicated
to alleviating the incidence, degree and
consequence of physical pain. Progress
on Pain works with the entertainment
industries to encourage the accurate
depiction of chronic pain and modem
methods of its relief in film and
television. The organization's work is
based on research indicating that a
large percentage of Americans get
most of their health care information
from these media.
Invitees to the August 20th meeting
included experts in the field of pain

O

management and over 30 writers from
such popular television shows as ER,
Law & Order, Strong Medicine.
Judging Amy and The Practice. Each

of the expert panelists spoke about his/
her work in the field of pain management. Hoffmann spoke about "Pain
and the Law," in particular, the
criminal arrest and prosecution of
physicians who have prescribed large
dosages of opioid analgesics (which
are highly regulated under the Federal

Controlled Substances Act). Hoffmann
has been a Mayday Scholar for several
years, focusing much of her research
on legal and financial obstacles to
adequate pain treatment (see article
page 10). Other experts included
David Borsook, MD, PhD, founder,
Descartes Therapeutics, Inc., and
Associate Professor at Harvard Medical
School, who spoke on "Pain and the
Brain"; Maryland Pao, MD, National
Institutes of Mental Health, who
discussed "Children and Pain"; and
Virginia Sun, MSN, RN, Research
Specialist, City of Hope National
Medical Center, who shared results of
a study about how patients describe
their pain.
The Mayday Foundation hopes that

Cont. on page 16

Robin F. Wilson
Cont. from page 9

Assisting Seniors" program work to
increase South Carolina seniors'
awareness of, and enrollment in, the
Medicare program.
Much of Wilson's scholarship has
been about issues at the intersection of
health law and family law. In 2002,
Wilson's article "The Cradle of Abuse:
Evaluating the Danger Posted by a
Sexually Predatory Parent to a Victim's
Siblings," was published in the Emory
Law Journal. In addition, in that same
year, her piece "Fractured Families,
Fragile Children: The Sexual Vulnerability of Girls in the Aftermath of Divorce," appeared in the Child and
Family Law Quarterly. In this article,
Wilson surveyed the sociological
literature on child sexual abuse and
argued that young girls are at elevated
risk of being sexually abused after their
parents divorce. Most recently, Wilson
published an article in the American
Journal of Law & Medicine on
surrogacy.' In the article she argued
that the requirement imposed by many
states that intended parents (in surrogacy arrangements) be infertile may be
protective of the resulting children,
despite the fact that it was imposed to
10

decrease the number of couples
entering into surrogate parenting
arrangements.
Recently. Wilson has been traveling
around the world presenting some of
the results of her research. This past
July she spoke on "Making Child Abuse
Research Work to Protect Kids," at the
meetin g of the Commission on Anthropology of Children, Youth and Childhood, international Union of Anthropological and Ethnological Sciences, in
Florence, Italy. In August, Wilson
presented her research on the threat
posed by sexually abusive parents to the
Ninth Regional European Conference on
Child Abuse and Neglect of the International Society for the Prevention of
Child Abuse & Neglect in Warsaw,
Poland. Wilson also presented these
findings to the 2003 Annual Convention
of the South Carolina Trial Lawyers
Association in Hilton Head Island, South
Carolina in August.
In her current academic research.
Wilson is focusing her attention on
issues relating to the scope of consent
given by patients at academic medical
institutions prior to surgeries performed under anesthesia. Her own
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research and that of others found that
at many medical schools, students are
permitted to perform pelvic exams on
women who are under anesthesia for
purposes of training without the
women's consent. This summer,
Wilson testified at the Federal Trade
Commission and the Department of
Justice Hearings on Health Care and
Competition Law and Policy with
regard to "Unauthorized Practice: The
Use of Anesthetized and Deceased
Patients Without Consent to Train
Medical Professionals." Wilson's
testimony at the hearing was featured
in CNN Headline News and Good
Morning America segments and was
the subject of an article that appeared
in the June 25, 2003, Chicago Tribune.
This fall, she plans to hold a meeting at
the School of Law on how Schools of
Medicine are responding to this
criticism. Welcome Professor Wilson!
Footnotes
Robin Fretwell Wilson, "Uncovering the
Rationale for Requiring Infertility in Surrogacy
Arrangements," 29 American Journal of Lati ,
1

& Medicine 337 (2003).

Spotlight on Adjuncts:
Professor Lewis Noonberg, JD
hv.4llison Gail/en, LD2

ewis Noonberg, a 1962 graduate
of the School of Law, has
taught the "Antitrust in Health
Care," seminar at the law school for
over 15 years. As a partner in the
Washington, DC office of Piper
Rudnick, LLP and Chair of Piper
Rudnick's Antitrust Practice Group, he
brings decades of experience to the
classroom. Professor Noonberg began
teaching at the School of Law in 1967,
at which point he taught classes such
as federal jurisdiction and antitrust.
Mr. Noonberg began to teach "Antitrust in Health Care" when a significant
portion of his antitrust practice shifted
to the health care sector.
"Antitrust in Health Care" focuses on
the effects of antitrust law on the
delivery, quality, and efficiency of the
American health care system. The
seminar considers the tension between
institutional and individual providers, as
well as between third party payors, and
consumers. In addition, Professor
Noonberg examines the policy questions raised by the application of
traditional antitrust principles to the
health care industry.
Throughout his years of teaching this
course there have been tremendous
changes in antitrust enforcement and
health care. Antitrust enforcement
priorities have focused on different
industries at different times. In the
1970s, antitrust enforcement focused
for the first time on the real estate
industry; however, by the early 1990s,
antitrust enforcement focused on the
securities industry. Historically,
antitrust enforcement did not cover
professional services , but this began to
change in the late 1970s. In 1984,
Justice Stevens wrote the majority
opinion in.Iefferson Parish Hosp. Dist.
No. 2 v. Hyde, 104 S.Ct. 1551, holding
that a hospital's contract with a firm of
anesthesiologists, requiring all
anesthesiological services for the
hospitals' patients to be performed by
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that firm, was subject to the Sherman
Act, which prohibits contracts that
restrain trade. This decision led the
way for the increased application of
antitrust principles to the health care
industry.
Furthermore, during this time, as
competition increased it became
common for hospitals to merge with
one another, focusing sustained
antitrust attention on the industry.
Even today mergers remain commonplace in the health care industry,
despite relatively low rates in other
industries. Similarly, many non-profit
hospitals have recently begun to merge.
These mergers raise questions about
the application of antitrust law to true
non-profit health care entities. In U.S.
v. Long Island Jewish Medical Center.
983 F.Supp. 121, the court held that
antitrust principles can, in fact, be
applied to non-profit institutions.
Application of antitrust principles to
not-for-profit hospitals is just one of
the interesting recent legal developments that Professor Noonberg
discusses with his students in the
seminar.
Professor Noonberg believes that
many antitrust legal developments have
extremely important public policy

implications. For example, in 1984,
Judge (now Justice) Breyer, writing
for the First Circuit became the first
court to hold that the third party payor
is the surrogate for the consumer, and
its downward pressure on prices was
pro-competitive. Kartell v. Blue Shield
of Massachusetts, Inc., 749 F.2d 922
(1st. Cir. 1984). This finding has
repeatedly been upheld and led the way
for much debate on the policy implications of allowing third party payors to
"speak" for consumers. Professor
Noonberg finds the "third party payors
as consumers" principle to be one of
the most fascinating developments in
health care antitrust and concentrates
on this interplay in the classroom.
Throughout the years that Professor
Noonberg has taught at the School of
Law, he has routinely been impressed
with the caliber of students that enroll
in "Antitrust in Health Care." He finds
that the course attracts students with
interesting backgrounds. Prior to
coming to law school, many of the
students worked as physicians, nurses,
or hospital administrators. Through
the students' backgrounds, the class
gains insight into the practical issues in
health care antitrust. For example, it is
often difficult to measure the power of
hospitals in the market because, as
opposed to other industries, many
different factors are at work. The
students, through their backgrounds,
are able to identify in the real world the
factors at stake. In addition, Professor
Noonberg remains impressed that his
students can still raise issues that he
had not considered. He finds teaching
"Antitrust in Health Care" to be a
wonderful adjunct, in the truest sense
of the word, to his professional career.
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Fall Happenings
L&HCP Interdisciplinary Courses
Since 1990, Professor Diane Hoffmann
has offered a multidisciplinary course
called "Critical Issues in Health Care"
to students from the Schools of Latin,
,Lledicine, Nursing, Pharmacy,
Dentistry and Social Work. The
popularity of this course led the School
of Law to recently establish two new
multidisciplinary courses with a health
law focus.

New Course on
Homeland Security
his fall, Professor Michael
Greenberger, the Director of
the University of Maryland Center for Health and Homeland Security
(CHHS), is offering a one-credit course
entitled: "Homeland Security: The Interdisciplinary Study of Crisis and
Health Consequence Management
Policy in the Era of Counterterrorism."
Half of the class is comprised of students from the School of Law and the
other half are from the School of Medicine.
Sadly, terrorist activities that have
taken place domestically have created
the need for a collaborative plan that
connects health care and law enforcement professionals. That is, both "crisis management," the law enforcement
response to terrorist threats or acts of
terrorism, and "consequence management," the measures taken to protect
public health and safety after a ter rorist
threat or attack, require that law enforcement officials, legal professionals,
first responders and other health professionals collaborate to effectively assist citizens in the event of an attack.
Professor Greenberger's course seeks
to bring together students from health
care and legal educational programs to
ensure that future crisis responders are
well-prepared to protect the nation's
infrastructure and safety of its citizens.
Students in Greenberger's course
will examine the definition of terrorism,
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the underlying issues that motivate terrorists to act, weapons used by terrorists and theories of crisis and consequence management. Assigned readings include a combination of periodical
articles, law review articles and legal
cases that discuss current issues in
homeland security. Guest lecturers
from each of the University of Maryland-Baltimore professional schools will
discuss their perspectives and will
share their research as it relates to
threats to the safety of the nation. Dr.
Jim Campbell, a clinical vaccine trial
specialist at the University of Maryland
School of Medicine's Center for Vaccine Development and Dr. Colin
Mackenzie, the Director of the School
of Medicine's National Study Center
for Trauma and Emergency Medical
Systems, will address Professor
Greenberger ' s class. In addition, outside health policy and homeland security experts including Jason Sapsin, a
faculty member at the Department of
Health Policy and Management at the
Johns Hopkins Bloomberg School of
Public Health, and Dr. Ellen Gursky, a
Senior Fellow for Biodefense and Public Health Programs at the Advancing
National Strategies and Enabling Results (ANSER) Institute for Homeland
Security in Arlington, Virginia will also
participate as guest lecturers. Professor
Greenberger has no doubt that these
health and policy experts will enrich the
students' understanding of the complexities facing medical and legal professionals as the United States faces unanticipated health and security challenges.

New Course on
Conflicts in Health
Care
rofessor Roger Wolf, Director of
the School of Law's new Center
for Dispute Resolution, is offering a new interdisciplinary course this
fall on "Conflicts in Health Care."

P
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While Wolf took the lead in bringing
the course together, the course is being
team taught by faculty from the
Schools of Law, Medicine and Nursing
who have taught conflict resolution or
managed conflicts as part of their professional role. These faculty members
include Mary Etta Mills, Chair of the
Department of Education, Administration, Health Policy and Informatics at
the School of Nursing; Nancy Lowitt,
Associate Dean in the Office of Graduate and Continuing Medical Education
at the School of Medicine; Diane
Hoffmann, Associate Dean and Director of the Law & Health Care Program
at the School of Law; Joseph Proulx,
Professor at the School of Nursing;
Michael Rolnick, Assistant Professor
of Surgery at the School of Medicine;
and Mary Tilbury, Assistant Professor
in the Department of Education, Administration, Health Policy and
Informatics at the School of Nursing.
This unique course will examine
theories of conflict management,
sources of conflict, and various methods of managing conflicts in health
care settings. Students in the
multidisciplinary course will focus their
study on disputes that occur between
medical professionals, patients and
staff, as well as disputes that take place
at the institutional level, i.e., issues resulting from regulation and reimbursement. The class will provide interactive opportunities for a cross-section of
professional students to enhance their
conflict management styles through
simulations and case studies. In addition to improving the students' ability
to address conflicts after they occur,
the course also seeks to help students
identify the early indicators of conflicts, so that appropriate interventions
take place to avoid disputes. Professor
Wolf believes that by bringing together
future health care professionals and future health policy makers, collaboration
and avoidance of conflict can be
achieved in health care settings.

Fall Happenings
Medical Malpractice Roundtable
at the School of Law
he School of Law's Center for
Dispute Resolution and the Law
& Health Care Program, in
conjunction with the University of
Maryland Schools of Medicine and
Nursing will sponsor a roundtable
discussion about issues relating to
medical malpractice insurance in
Maryland on October 28, 2003, at the
School of Law. invited participants
include approximately 50 individuals
representing physician groups, insurers,
trial attorneys, legislators, academics
and consumer groups to discuss the
ways in which increased malpractice
insurance premiums impact the delivery
of health care services in Maryland.
The high cost of medical malpractice
insurance has reached crisis proportions in many states. In New Jersey
and West Virginia, doctors have gone
on strike to protest the cost of malpractice premiums. High malpractice
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insurance rates forced the University of
Nevada Medical Center to discontinue
trauma care. In addition. malpractice
premiums in specialties that are
perceived to be high-risk now regularly
exceed $100,000 per year. Costly
medical malpractice premiums in highrisk specialties force specialists to
make decisions that adversely affect
patients, such as relocating their
practices to states that have lower
medical malpractice premium rates,
eliminating patient services, retiring or
postponing the purchase of new
equipment.
In Maryland, several malpractice
insurers have withdrawn from the
market and insurers that remained in
the market have increased malpractice
premiums substantially. Further.
among the University of Maryland
School of Medicine's 2003 graduates,

not one student selected a residency in
obstetrics/gynecology, a high-risk
specialty whose doctors are often
subject to lawsuits.
The first part of the program on
October 28 will include a presentation
of the history of medical malpractice
issues in Maryland, as well as data on
trends in malpractice cases and
insurance premiums. Speakers will
include Susan Russell, Maryland
Legislative Services. Frank Clemente.
Public Citizen, Randall Borbjerg, The
Urban Institute. Tom Metzloff, Duke
University Law School, and Rick
Kidwell, Johns Hopkins Health System.
The roundtable discussion that will
follow will examine proposed solutions
to the medical malpractice premium
increase in Maryland.

Lisa Ohrin Accepts New Job
irst the Good News ... Lisa
Ohrin, who has served as the
Coordinator of the Law & Health
Care Program and Director of its
Externship and Practicum Program for
the last three years, has accepted the
position of Legal Counsel with the
Office of General Counsel at Beth
Israel Deaconess Medical Center. In
this position, Ohrin will primarily focus
on payment and reimbursement matters
as well as other legal issues. This is a
fantastic opportunity for career
advancement for Ohrin.

F

Now the Bad News . . . Beth Israel
is located in Boston! Ohrin's last day
with the Law & Health Care Program
was September 2'. She has been a
great counselor to students in the
Program. providing them with advice
about courses, externships, and jobs.
She will be sorely missed. Though she
will be in New England, Ohrin will
continue to stay in touch with students
and friends here at Maryland. We
wish her the best of luck in her future
endeavors!
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Focus on . .

STUDENTS
Student Health Law Organization (SHLO) News
by Allison Guillen, LD2,
President, SHLO

he Student Health Law Organization (SHLO) works closely
with the nationally ranked Law
& Health Care Program to provide
University of Maryland law students
with many opportunities to enhance
their knowledge of health law issues and
to introduce them to area practitioners.
SHLO has more than seventy-five
members and began the 2003-2004
school year with several activities. The
SHLO Executive Board's first task was
to welcome the first year students and
to provide them with information about
Sl ILO at the annual Student Organization Fair held on August 20'. SHLO's
first meeting of the school year was
held on September 17`'', at which
students warmly welcomed Robin
Wilson, who is visiting this year at the
School of Law and who is teaching one
of the L&HCP core courses, The
Patient-Provider Relationship. (See
article on page 9.)
In addition, on September l7''' SHLO
commenced its annual "Brown Bag
Lunch Speaker Series." This lunchtime speaker series allows students to
learn about contemporary health care
law issues in an informal, small setting.
The first scheduled speaker was
Roberta Ward, `82, Privacy Officer
and Senior Counsel, California Department of Health Services. Ward spoke
with students about the challenges of
HIPAA compliance for government
health plans. On September 22°'',
SHLO hosted a meeting of the Maryland State Bar Health Care and Elder
Law Sections. At this meeting,
students were able to network with
practicing attorneys in various areas of
health care and elder law. Martha Ann
Knutson, the General Counsel of Upper
Chesapeake Health, moderated a
discussion about In Re: Sophia Foley.
373 Md. 627. a recent Maryland Court
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The 2003 - 2004 SHLO E_reccrtitie Board
members are (from left to right): Rachel
Xlel! y. Vice President, Annie Garibaldi,
Fundraising Chair, Allison G ll/en, President,
and Samantha Elena Freed, Secretary. Not
pictured: Michelle Valenti, Treasurer and
Sabrina Chase. Liaison to .4HLA

of Appeals decision that addressed the
legal tensions between the powers of a
health care agent and a petitioner for
guardianship contesting the agent's
actions. Jack Schwartz, the drafter of
the amicus brief submitted by the

Attorney General, as well as Mike
Davis and Mitch Mirviss, the attorneys
who argued the case before the Court
of Appeals, participated in the panel
discussion.
In addition to these activities, on
Sept. 21-23'id. SHLO members had the
opportunity to volunteer at the American Health Lawyers Association's
(AHLA) conference on fraud and
compliance as part of SHLO's ongoing
affiliation with AHLA. On October 23,
SHLO will hold the third annual "What
is Health Law?" panel, at which several
health law practitioners will speak to
students about various professional
opportunities within the field of health
care law.
Throughout the school year SHLO
will hold several other programs. All
of SHLO's programs are intended to
educate students about health law and
to assist them in navigating through the
extensive array of health related
courses and opportunities offered by
the Law & Health Care Program.

TheJournal of Health Care Law & Policy
QHCL&P)
This fall, the JHCL&P begins its seventh year of operation.
The 2003-2004 editorial officers are:
Editor-In-Chief: Kristine L. Callahan
Senior Articles Editor: Wendy L. Williams
Executive Editor: Heather L. Balsley
Managing Editor: Stacy Barceilona
Assistant Managing Editor: Daniel S. Shaivitz
Notes & Comments Editors: Derek Stikeleather and John Susoreny
Articles Editors: Robert Griffith, Ella Judge Hayes, Amanda S. Pitcher,
Thomas R. Riggs. and Hayward West
Associate Editors: Vincent M. Guida, Jr., Amber D. Howard, Jessica R. Myles,
Staci L. Pipkin. Duane N. Scott, Karen Smith Thiel, Ph.D.,
Michael J. Wasicko, Ph.D., and Michael Winschel

The JHCL&P is calling for articles on current issues in health law and
policy for the Spring 2004 edition of the Journal. Articles should be
submitted to JHCLP@Iaw.umaryland.edu by December 15, 2003.
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STUDENTS
NSHLA:
Partnering with
AHLA to
Prepare Future
Health Lawyers
uring the past year,
Maryland's Student Health
Law Organization (SHLO), in
conjunction with the American Health
Lawyers Association (AHLA), began
to organize a national student health
law interest group. Members of SHLO
have routinely sponsored programs at
the law school that allow students
interested in health law to meet and
interact with local health law attorneys
and have attended local AHLA conferences, often volunteering to work a
shift at the conference in exchange for
being able to attend other conference
sessions. The organization's leaders
realized that additional benefits could
come from working with AHLA on the
formation of a similar student group at
the national level.
The idea was in large part borrowed
from a similar organization that exists
for students in environmental law.
SHLO members saw that the National
Association of Environmental Law
Societies, a student group that held its
annual conference at the University of
Maryland School of Law in March
2003, served as an invaluable educational resource for students interested
in environmental law. SHLO members
believed that a national student health
law interest group could also provide
an educational and professional
resource to law students.
SHLO contacted several health law
faculty members at law schools with
prominent health law programs and the
faculty members then recommended
student leaders to participate on the

D

HEALTH LAW PRACTICUMS AND
EXTERNSHIPS:

National Cancer Institute
by Jonathan Locker

his past summer I worked as a
research assistant for the
National Cancer Institute in the
division of Epidemiology and Population Studies. 1, along with another law
student from Maryland, was given the
task of doing research for a paper on
how Federal Courts use epidemiological evidence in making their decisions.
The goal of this paper was to see if
epidemiological evidence was being
improperly used in tort cases.
I worked in the corporate world for
three years before starting law school,
and wanted to experience something
different from a standard office
environment. I was attracted to the
NCI for its noble purpose and unique
role in the war against cancer. Guessing that whatever I would end up doing
at the NCI would be quite different
from what I would see at a law firm, I
decided it would be a good first
experience with the law outside the
classroom.
The NCI is composed mostly of
physicians who research causes of and
cures for various forms of cancer. In
this environment, creating ideas takes
priority over creating dollars. During
the practicum I was encouraged to
attend lectures that would benefit my
education, but would not advance my
project. The lecture I attended on the
ethics of medical trials showed how
inadequate the law can be when it deals
with ethical issues. For example, I
was surprised to learn that there is no
federal statute requiring patient consent
to medical trials. The requirement is
achieved through a patchwork of tort
law and federal regulations. Needless
to say 1 was surprised and wondered
how many legal puzzles remained out
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there in the world.
In between schmoozing with the
myriad of doctors and attending
lectures, I conducted legal research.
Specifically, I searched through 500
federal cases that had used the Supreme Court's 1993 Daubert standard
with respect to admissibility of scientific evidence. My task was to find
cases that analyzed how epidemiological evidence is used by the courts to
establish causation in toxic tort cases.
After whittling the number of relevant
federal cases to 145, I then examined
whether the respective courts' analyses
could be applicable to NCI studies.
At the outset of my research, my
cynical nature led me to believe that
most courts would allow any evidence
to be used as long as an "expert" with
a bunch of letters behind his name said
it was scientific proof. However, the
analysis showed that courts do not
admit "junk science," and that judges
have become increasingly sophisticated
about scientific evidence. It would
seem that judges are quite wary of
allowing unsubstantiated scientific
evidence into the courtroom. I must
say I was surprised and proud that my
chosen profession was not succumbing to "junk science."
At the end of the summer, after
going over more than 500 cases and
reworking the cases that would be
used for the paper, 1 was relieved to be
finished with the work. I did, however, enjoy the people and the atmosphere at the NCI, and found that
working in a government environment
can have its advantages. Overall, NCI
was an excellent place to get a taste of
the law outside of the world of large
law firms.
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Hollywood
Cont. from page 10

National Student Health Law
Association

Cont. from page 14
as a result of these roundtables, writers
and producers whose work is distributed in mass media outlets will use the
information that they learned about pain
and will develop future storylines that
illustrate the impact that pain has on the
lives of individuals, obstacles to
adequate pain treatment and how pain
can be successfully treated. Hoffmann
stated that the experience was informative and fun. She found that the
writers and producers were intrigued
by the recent breakthroughs in the
diagnosis and treatment of pain and
looks forward to seeing an upcoming
episode of Law & Order or ER that
incorporates one of the stories that she
or the other panelists shared.

steering committee for the national
group. Linda Batten from the Indiana
University School of Law-Indianapolis,
Melissa Bezet from the University of
Houston, Lisa Daley from the University of Maryland, Joe Hudzik from St.
Louis University, Melissa January from
Loyola University, and Heather Meade
from the University of Washington,
volunteered to participate in the
formation of the National Student
Health Law Association (NSHLA). In
March 2003, these students discussed
the aims and structure of a national
health law interest group via conference call.
During the ALILA Annual Meeting,
held in San Antonio, Texas from June
29-July 1, 2003, many of the student
members of the NSIiLA steering
committee met to further elaborate
plans for NSHLA. With the help of
AHLA, the students outlined future
plans to provide the most current
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health law information and programming for students interested in health
law. In addition, the students discussed ways that NSHLA could
improve collegiality among law students interested in health law and made
plans to increase membership in the
organization by contacting other law
schools with health law programs.
In November 2003, NSHLA hopes to
host the first of a series of regional
conferences during AHLA's Fundamentals of Health Law conference in
Chicago. Law students from around
the country will be invited to attend
presentations about developments in
the health law arena. NSHLA and
AHLA hope that the Chicago conference will be the first of many opportunities to develop strong connections
between future health law practitioners
and seasoned health law attorneys,
thereby ensuring that law students
entering the marketplace are wellprepared to tackle the challenges
presented by a rapidly evolving area of
the law.
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